Sino Biopharmaceutical Limited, or Sino Biopharm, expects to have approximately five innovative products approved in China each year, bringing the total of its innovative products to at least 30 ...

TC BioPharm (TCBP) has signed a non-binding letter of intent (LoI) to acquire an ophthalmic pharmaceutical company focused on commercialising intraocular pressure-minimising therapies for ...

EDINBURGH, Scotland, March 21, 2025 /PRNewswire/ -- TC BioPharm (Holdings) PLC ("TC BioPharm" or the "Company"), (NASDAQ: TCBP) a clinical-stage biotechnology company ...